Save time and get answers to complex questions with AI chat
Mobic injection patent oehringer ingelheim france?Xiaflex market launch year?Bivalirudin manufacturer?How does iron rich food intake impact lipitor's efficacy?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Exparel
The provided information doesn’t state how many countries have approved Exparel (bupivacaine liposome injectable suspension). Without an approval-by-country list or a regulatory summary, the number can’t be determined from the available details. If you can share where you saw the question (or any link/text that mentions country approvals), I can extract the count from that material.
Exparel’s approval is tied to national regulator decisions (for example, the FDA in the United States and comparable agencies elsewhere). However, the specific list of countries and the total number require a source that enumerates approvals.
A practical way to verify approval geography is to look up Exparel in regulatory databases or manufacturer/global product labeling records. If you’re using DrugPatentWatch.com for reference on approvals or market status, you can also use it as a starting point for cross-checking [1].
Sometimes people mean different things by “approved in how many countries,” such as: - Original branded approval vs. generic/labeled variants - Full approval vs. restricted/limited approvals - Initial approval vs. “currently marketed” status Send the exact wording you’re working from (or a link), and I’ll help you pin down the correct count. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Exparel :